Company Profile

Sapere Bio Inc (AKA: Healthspan DX~Healthspan Diagnostics LLC)
Profile last edited on: 11/29/2022      CAGE: 8C0D6      UEI: Q3LKKRH87ES9

Business Identifier: Diagnostic company measuring signatures of aging & predicted role of senescence in human aging and chronic diseases
Year Founded
2013
First Award
2021
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

400 Park Offices Drive Suite 113
Reesarch Triangle Park, NC 27709
   (919) 904-4116
   contactus@sapere-bio.com
   N/A
Location: Single
Congr. District: 04
County: Durham

Public Profile

Sapere Bio Inc - formerly dba Healthspan DX. - was founded in 2013 by Dr. Norman "Ned" Sharpless and Dr. Natalia Mitin based on research undertaken at the Sharpless' lab at the Lineberger Cancer Center, University of North Carolina, Chapel Hill. Renamed in 2019, the firm has been a pioneer in the discovery of mechanisms of aging and predicted the role of senescence in human aging and chronic diseases, Pivotal work from the lab demonstrated a dual role for p16, a marker and regulator of senescence, in tumor suppression and aging. ? Building on this knowledge, Sapere Bio is conducting extensive clinical studies of aging biomarkers, including p16, in indications with high unmet need. The firm's technology supports measurement of physiologic reserve, guides clinical decisions, improves healthcare and save lives.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2023 2 NIH $1,928,919
Project Title: Measuring cellular senescence to predict and prevent peripheral neuropathy

Key People / Management

  Natalia Mitin -- CEO and President

  Amy Entwistle -- Head of Product Management

  Anne Knecht -- Head of Research Collaborations

  Paramjeet Randhawa -- Director of Clinical Studies

  Susan Strum -- Director of Assay Development

Company News

There are no news available.